5037 Investors following JB Chemicals. Share this News with them.
0
Like this story, share it with millions of investors on M3
Gilead inks licensing pacts with 4 Indian firms
US drug maker Gilead has signed licensing agreements for its second-generation anti-AIDS drug Tenofovir with four Indian companies. CNBC-TV18 learns that it has chosen Aurobindo Pharma, JB Chemicals, Alkem and Shasun Chemicals for the deals.
US drug maker Gilead has signed licensing agreements for its second-generation anti-AIDS drug Tenofovir with four Indian companies. CNBC-TV18 learns that it has chosen Aurobindo Pharma , JB Chemicals , Alkem and Shasun Chemicals for the deals.
Gilead also has similar deals with Strides Acrolab, Emcure and Hetero Drugs.
The US drug maker will provide manufacturing technology to these seven companies, and in return get a 5% royalty.
Gilead is also in talks with two companies for a marketing alliance to sell its branded anti-AIDS drug- Viread - in India.
Gregg H Alton, Sr VP, Gilead Sciences says, "We are in talks for this marketing alliance and we should be announcing something in the next 2 weeks."
Gilead has also filed a patent for Viread in India. But Cipla has opposed the pre-grant of the patent.
